Phase
Condition
Dyslipidemia
Diabetes And Hypertension
Diabetes Prevention
Treatment
Choline fenofibrate
Policosanol
Clinical Study ID
Ages > 20 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Type 2 diabetes under treatment with HbA1c 6.0-10.0% at screening visit
Male or female of 20 years or over
Mixed dyslipidemia: triglyceride 200~499 mg/dL, HDL-cholesterol male ≤45 mg/dL orfemale ≤50 mg/dL
Identified carotid artery plaque: carotid intima-media thickness (cIMT) ≥ 1.0 mm
Creatinine ≤1.8 mg/dL
Exclusion
Exclusion Criteria:
Dyslipidemia which requires other therapy: triglyceride ≥500 mg/dL orLDL-cholesterol ≥190 mg/dL
Uncontrolled hypertension
Severe renal dysfunction
GOT/GPT >120/120 or chronic liver disease
Pregnant or childbearing woman who does not have enough contraception
Changes of medication related to chronic diseases (diabetes, hypertension,dyslipidemia, etc.) within 3 months
Other antiplatlet medication such as cilostazol, clopidogrel (except aspirin)
Study Design
Study Description
Connect with a study center
SNUBH
Seongnam, Gyeonggi 13620
Korea, Republic ofSite Not Available
SNUBH
Seongnam-si, Gyeonggi-do 13620
South KoreaActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.